Related Experiment Videos
[21-arginine-A] insulin: a biologically active analog
Summary
Researchers synthesized a sheep insulin analog replacing A21 asparagine with arginine. This [Arg21-A] sheep insulin analog retains biological activity but is approximately 50% as potent as natural insulin.
Area of Science:
- Biochemistry
- Endocrinology
- Protein Chemistry
Background:
- Insulin's biological activity is crucial for glucose homeostasis.
- The A21 asparagine residue in the insulin A chain is proposed to be critical for hormone function.
- Understanding structure-activity relationships of insulin analogs can reveal insights into its mechanism of action.
Purpose of the Study:
- To synthesize and characterize a novel sheep insulin analog with arginine at the A21 position.
- To investigate the impact of substituting A21 asparagine with arginine on insulin's biological potency and activity.
- To explore the role of the A21 residue's side chain in insulin's overall function.
Main Methods:
- Synthesis of the [Arg21] A chain of sheep insulin using fragment condensation.
- Isolation of the S-sulfonated A chain derivative.
- Conversion to sulfhydryl form and interaction with S-sulfonated B chain to form [Arg21-A] sheep insulin.
- Purification using carboxymethylcellulose chromatography with a sodium chloride gradient.
- Potency assays including mouse convulsion method and radioimmunoassay.
Main Results:
- The [Arg21-A] sheep insulin analog was successfully synthesized and purified.
- The analog exhibited reduced potency, approximately 50% of natural sheep insulin (10.5–12.5 IU/mg vs. 23–25 IU/mg).
- Despite retaining proposed critical interactions, the analog's diminished activity suggests other factors influence biological function.
Conclusions:
- The substitution of A21 asparagine with arginine in sheep insulin significantly reduces biological potency.
- The A21 residue's side chain plays a role in insulin activity beyond established salt bridge and hydrogen bond interactions.
- Further investigation is needed to elucidate the specific factors involving the A21 side chain that affect insulin's biological activity.